Page last updated: 2024-08-22

fluorescein-5-isothiocyanate and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

fluorescein-5-isothiocyanate has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brorholt-Petersen, JU; Faergeman, O; Jensen, HK; Raungaard, B1
Iwano, C; Matsuyama, K; Matzno, S; Nishikata, M; Yasuda, N1
Enomoto, S; Fukuda, D; Nagai, R; Sata, M; Shirakawa, I1

Trials

1 trial(s) available for fluorescein-5-isothiocyanate and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Flow cytometric assessment of effects of fluvastatin on low-density lipoprotein receptor activity in stimulated T-lymphocytes from patients with heterozygous familial hypercholesterolemia.
    Journal of clinical pharmacology, 2000, Volume: 40, Issue:4

    Topics: Amino Acid Substitution; Antibodies, Monoclonal; Anticholesteremic Agents; Carbocyanines; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Data Interpretation, Statistical; Fatty Acids, Monounsaturated; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluvastatin; Heterozygote; Humans; Hyperlipoproteinemia Type II; Indoles; Lipoproteins, LDL; Mutation; Protein Binding; Receptors, LDL; T-Lymphocytes; Triglycerides

2000

Other Studies

2 other study(ies) available for fluorescein-5-isothiocyanate and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Evaluation of apoptosis and necrosis induced by statins using fluorescence-enhanced flow cytometry.
    Journal of pharmaceutical and biomedical analysis, 2005, Sep-15, Volume: 39, Issue:3-4

    Topics: Apoptosis; Atorvastatin; Avidin; Biotin; Cell Line; Cell Separation; Cells, Cultured; Drug Industry; Drug Screening Assays, Antitumor; Fatty Acids, Monounsaturated; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Leukemia; Microscopy, Fluorescence; Necrosis; Pharmaceutical Preparations; Pravastatin; Propidium; Pyridines; Pyrroles; Simvastatin; Time Factors

2005
Fluvastatin accelerates re-endothelialization impaired by local sirolimus treatment.
    European journal of pharmacology, 2009, Jun-10, Volume: 612, Issue:1-3

    Topics: Animals; Bone Marrow Transplantation; Cells, Cultured; Endothelium, Vascular; Fatty Acids, Monounsaturated; Female; Femoral Artery; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Fluvastatin; Humans; Immunohistochemistry; Immunosuppressive Agents; Indoles; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Platelet Endothelial Cell Adhesion Molecule-1; Random Allocation; Sirolimus; Time Factors; Tunica Intima; Tunica Media

2009